Pharmaceutical GMP readiness in Switzerland
Switzerland regulates medicines through Swissmedic under the Therapeutic Products Act (TPA / HMG SR 812.21) and the Medicinal Products Licensing Ordinance (AMBV/OAMéd). Swiss GMP follows PIC/S; the EU–Switzerland Mutual Recognition Agreement (MRA) means EU and Swiss GMP inspections recognize each other for human medicines. Batch release uses a Swiss Qualified Person (Fachtechnisch verantwortliche Person, FvP). This guide covers the Switzerland-specific layer over an ICH Q10 PQS.
Regulator and legal basis
FvP / Qualified Person and licence model
EU MRA, GDP, and serialization
Inspection style and common findings
A 90–180 day Switzerland readiness path
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Swissmedic — the Swiss Agency for Therapeutic Products (Schweizerisches Heilmittelinstitut / Institut suisse des produits thérapeutiques) — Switzerland's national competent authority for medicines + medical devices.
QP release means a Qualified Person must personally certify each batch complies with its authorisation and GMP before it can be supplied in the EU or UK.
EU GDP defines how medicines must be stored, handled, and transported so quality and authenticity are preserved from manufacturer to pharmacy, with licensed wholesalers and brokers operating under a robust quality system.
Annex 1 sets the modern, risk-based standard for sterile manufacturing, requiring a holistic contamination control strategy, robust aseptic operations, and documented evidence that facilities and processes consistently protect patients.
Annex 11 defines how GMP computerized systems must be validated, controlled, and monitored to protect product quality and patient safety across the EU, with strong data integrity and lifecycle expectations.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Frequently asked
Does the EU–CH MRA cover all medicines?
Is FvP the same as an EU QP?
Do we need FMD serialization for Swiss packs?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
- Australia pharmaceutical GMP readiness — TGA, PIC/S GMP, ARTG
- Brazil pharmaceutical GMP readiness — ANVISA, RDC 658/2022, CBPF, SNCM
- Canada pharmaceutical GMP readiness — Health Canada, FDR Div. 2, DEL
- China pharmaceutical GMP readiness — NMPA, Drug Administration Law, 2010 GMP
- EU pharmaceutical GMP readiness — EudraLex Vol 4, QP release, EU GDP
- GCC pharmaceutical GMP readiness — Saudi SFDA, GCC-DR, UAE MOHAP, RSD
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up